1. Sato KT et al: One-step
iodine starch method for direct visualization of sweating.
Am J Med Sci 295(6):528-531, 1988
2. Sato K: Normal and abnormal sweat gland function. In: Clinical Autonomic Disorders, edited by PA Low. Philadelphia, PA, Lippincott-Raven Publishers, 1997, pp. 97-108
3. Fealey RD: Thermoregulatory sweat test. In: Clinical Autonomic Disorders, 3rd edition, edited by PA Low, EE Benarroch. Philadelphia, PA, Lippincott Williams & Wilkins, 2008, pp. 244-263
4. Low PA et al: Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 14(5):573-580, 1983
5. Vetrugno R et al: Sympathetic skin response: Basic mechanisms and clinical applications. Clin Auton Res 13(4):256-270, 2003
6. Kennedy WR: Quantitation of the sweating deficit in diabetes mellitus. Ann Neurol 15:482-488, 1984
7. Sato K, Sato F: Individual variations in structure and function of human eccrine sweat gland. Am J Physiol 245(2):R203-R208, 1983
8. Cole DE, Boucher MJ: Use of a new sample-collection device (Macroduct) in anion analysis of human sweat. Clin Chem 32(7):1375-1378, 1986
9. Tetteh HA et al: Primary palmoplantar hyperhidrosis and thoracoscopic sympathectomy: A new objective assessment method. Ann Thorac Surg 87(1):267-274, discussion 274-265, 2009
10. Bonde P et al: An objective assessment of the sudomotor response after thoracoscopic sympathectomy. J Thorac Cardiovasc Surg 135(3):635-641, 2008
11. Fealey RD, Low PA, Thomas JE: Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 64(6):617-628, 1989
12. Hsieh C, McNeeley K, Chelimsky
TC: The clinical thermoregulatory sweat test induces maximal sweating.
Clin Auton Res 11(4):227-234, 2001
13. Morgan CJ et al: Cutaneous microdialysis as a novel means of continuously stimulating eccrine sweat glands in vivo. J Invest Dermatol 126(6):1220-1225, 2006
14. Kennedy WR, Wendelschafer-Crabb G, Brelje
TC: Innervation and vasculature of human sweat glands: An immunohistochemistry-laser scanning confocal fluorescence microscopy study.
J Neurosci 14(11 Pt 2):6825-6833, 1994
15. Sato F et al: Cystic fibrosis transport regulator and its mRNA are expressed in human epidermis. J Invest Dermatol 119(6):1224-1230, 2002
16. Eisenach JH, Atkinson JL, Fealey RD: Hyperhidrosis: Evolving therapies for a well-established phenomenon. Mayo Clin Proc 80(5):657-666, 2005
17. Hornberger J et al: Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 51(2):274-286, 2004
18. Strutton DR et al: US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey. J Am Acad Dermatol 51(2):241-248, 2004
19. Solish N, Benohanian A, Kowalski JW: Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: Effects on functional impairment and quality of life. Dermatol Surg 31(4):405-413, 2005
20. Shih CJ, Wu JJ, Lin MT: Autonomic dysfunction in palmar hyperhidrosis. J Auton Nerv Syst 8(1):33-43, 1983
21. Ma L et al:
Topiramate reduced sweat secretion and aquaporin-5 expression in sweat glands of mice.
Life Sci 80(26):2461-2468, 2007
22. Simonetta Moreau M et al: A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Br J Dermatol 149(5):1041-1045, 2003
23. Kim WO et al: Topical
glycopyrrolate for patients with facial hyperhidrosis.
Br J Dermatol 158(5):1094-1097, 2008
24. Swartling C et al: Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin. J Am Acad Dermatol 51(5):739-745, 2004
25. Schnider P et al: Treatment of focal hyperhidrosis with botulinum toxin type A: Long-term follow-up in 61 patients. Br J Dermatol 145(2):289-293, 2001
26. Richards RN. Ethyl chloride spray for sensory relief for botulinum toxin injections of the hands and feet. J Cutan Med Surg 13(5):253-256, 2009
27. Benohanian A: What stands in the way of treating palmar hyperhidrosis as effectively as axillary hyperhidrosis with botulinum toxin type A. Dermatol Online J 15(4):12, 2009
28. Davarian S et al: Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis. Australas J Dermatol 49(2):75-79, 2008
29. Kavanagh GM, Shams K: Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis. J Am Acad Dermatol 55(5 Suppl):S115-S117, 2006
30. Li X et al: Minimizing endoscopic thoracic sympathectomy for primary palmar hyperhidrosis: Guided by palmar skin temperature and laser Doppler blood flow. Ann Thorac Surg 87(2):427-431, 2009
31. Kim WO et al: Influence of T3 or T4 sympathicotomy for palmar hyperhidrosis. Am J Surg 199(2):166-169, 2010
32. Sugimura H et al: Thoracoscopic sympathetic clipping for hyperhidrosis: Long-term results and reversibility. J Thorac Cardiovasc Surg 137(6):1370-1376, discussion 1376-1377, 2009
33. Miller DL et al: Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis. J Thorac Cardiovasc Surg 138(3):581-585, 2009
34. Miller DL, Force SD: Temporary thoracoscopic sympathetic block for hyperhidrosis. Ann Thorac Surg 85(4):1211-1214, discussion 1215-1216, 2008
35. Mahdy T et al: T4 sympathectomy for palmar hyperhidrosis: Looking for the right operation. Surgery 143(6):784-789, 2008
36. Atkinson JL, Fode-Thomas NC, Fealey RD, Eisenach JH, Goerss SJ: Endoscopic transthoracic limited sympathotomy for palmar-plantar hyperhidrosis: Outcomes and complications during a 10-year period. Mayo Clin Proc 86(8):721-729, 2011
37. Westphal FL et al: Skin depigmentation: Could it be a complication caused by thoracic sympathectomy? Ann Thorac Surg 88(4):e42-e43, 2009
38. Weksler B et al: Transection of more than one sympathetic chain ganglion for hyperhidrosis increases the severity of compensatory hyperhidrosis and decreases patient satisfaction. J Surg Res 156(1):110-115, 2009
39. Boni R: Tumescent suction curettage in the treatment of axillary hyperhidrosis: Experience in 63 patients. Dermatology 213(3):215-217, 2006
40. Korpelainen JT, Sotaniemi KA, Myllyla VV: Autonomic nervous system disorders in stroke. Clin Auton Res 9(6):325-333, 1999
41. Gris D et al: Comparison of effects of
methylprednisolone and anti-CD11d antibody treatments on autonomic dysreflexia after spinal cord injury.
Exp Neurol 194(2):541-549, 2005
42. Krenz NR et al: Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury. J Neurosci 19(17):7405-7414, 1999
43. Ondarza AB, Ye Z, Hulsebosch CE: Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: Colocalization of GAP-43 and CGRP. Exp Neurol 184(1):373-380, 2003
44. Rabchevsky AG: Segmental organization of spinal reflexes mediating autonomic dysreflexia after spinal cord injury. Prog Brain Res 152:265-274, 2006
45. Weaver LC et al: Autonomic dysreflexia after spinal cord injury: Central mechanisms and strategies for prevention. Prog Brain Res 152:245-263, 2006
46. Hahn AF et al: Cold-induced sweating syndrome: A report of two cases and demonstration of genetic heterogeneity. J Neurol Sci 250(1-2):62-70, 2006
47. Rousseau F et al: Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient. Proc Natl Acad Sci U S A 103(26):10068-10073, 2006
48. Eedy DJ, Corbett JR: Olfactory facial hyperhydrosis responding to
amitriptyline.
Clin Exp Dermatol 12(4):298-299, 1987
49. Baskan EB et al: Localized unilateral hyperhidrosis and neurofibromatosis type 1: Case report of a new association. Dermatology 211(3):286-289, 2005
50. Laskawi R et al: Gustatory sweating: Clinical implications and etiologic aspects. J Oral Maxillofac Surg 57(6):642-648, discussion 648-649, 1999
51. Sethuraman G, Mancini AJ: Familial auriculotemporal nerve (Frey) syndrome. Pediatr Dermatol 26(3):302-305, 2009
52. Lai YT et al: Complications in patients with palmar hyperhidrosis treated with transthoracic endoscopic sympathectomy. Neurosurgery 41(1):110-113, discussion 113-115, 1997
53. Nesathurai S, Harvey DT:
Clonidine in the management of asymmetrical gustatory facial sweating: An N-of-1 trial.
Arch Phys Med Rehabil 77(9):906-908, 1996
54. Schick CH, Horbach T: Sequelae of endoscopic sympathetic block. Clin Auton Res 13(Suppl. 1):I36-I39, 2003
55. Mealey BL: Bilateral gustatory sweating as a sign of diabetic neuropathy. Oral Surg Oral Med Oral Pathol 77(2):113-115, 1994
56. Shaw JE et al: Gustatory sweating in diabetes mellitus. Diabet Med 13(12):1033-1037, 1996
57. Sheehy TW: Diabetic gustatory sweating. Am J Gastroenterol 86(10):1514-1517, 1991
58. Friedman JH: Hemifacial gustatory sweating due to Pancoast's tumor. Am J Med 82(6):1269-1271, 1987
59. Shaw JE et al: A randomised controlled trial of topical
glycopyrrolate, the first specific treatment for diabetic gustatory sweating.
Diabetologia 40(3):299-301, 1997
60. Urman JD, Bobrove AM: Diabetic gustatory sweating successfully treated with topical
glycopyrrolate: report of a case and review of the literature.
Arch Intern Med 159(8):877-878, 1999
61. Kreyden OP, Scheidegger EP: Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin Dermatol 22(1):40-44, 2004
62. Laccourreye O et al: Severe Frey syndrome after parotidectomy: treatment with botulinum neurotoxin type A. Ann Otolaryngol Chir Cervicofac 116(3):137-142, 1999
63. Drummond PD: Lacrimation induced by thermal stress in patients with a facial nerve lesion. Neurology 45(6):1112-1114, 1995
64. Drummond PD, Lance JW: Site of autonomic deficit in harlequin syndrome: Local autonomic failure affecting the arm and the face. Ann Neurol 34(6):814-819, 1993
65. Kalapesi FB, Krishnan AV, Kiernan MC: Segmental facial anhidrosis and tonic pupils with preserved deep tendon reflexes: A novel autonomic neuropathy. J Neuroophthalmol 25(1):5-8, 2005
66. Moon SY et al: Harlequin syndrome with crossed sympathetic deficit of the face and arm. J Korean Med Sci 20(2):329-330, 2005
67. Ghali FE, Fine JD: Idiopathic localized unilateral hyperhidrosis in a child. Pediatr Dermatol 17(1):25-28, 2000
68. Foshee JB et al: Eccrine angiomatous harmartoma in an infant. Pediatr Dermatol 23(4):365-368, 2006
69. Shapiro WR, Williams GH, Plum F: Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum. Brain 92(2):423-436, 1969
70. Sanfield JA et al: Altered
norepinephrine metabolism in Shapiro's syndrome.
Arch Neurol 46(1):53-57, 1989
71. Walker BR, Anderson JA, Edwards CR:
Clonidine therapy for Shapiro's syndrome.
Q J Med 82(299):235-245, 1992
72. Klein CJ et al: Basal forebrain malformation with hyperhidrosis and hypothermia: Variant of Shapiro's syndrome. Neurology 56(2):254-256, 2001
73. Benarroch EE, Stotz-Potter EH: Dysautonomia in fatal familial insomnia as an indicator of the potential role of the thalamus in autonomic control. Brain Pathol 8(3):527-530, 1998
74. Sage JI, Mark MH: Drenching sweats as an off phenomenon in Parkinson's disease: Treatment and relation to plasma
levodopa profile.
Ann Neurol 37(1):120-122, 1995
75. Fealey RD: Thermoregulatory failure. In: The Autonomic Nervous System II, vol. 75, edited by O Appenzeller. Amsterdam, Elsevier, 2000, pp. 53-84. Chapter 2
76. Jose BO et al: Hodgkin's lymphoma in adults—Clinical features. J Ky Med Assoc 103(1):15-17, 2005
77. Nadjar A et al: Brain cyclooxygenase-2 mediates interleukin-1-induced cellular activation in preoptic and arcuate hypothalamus, but not sickness symptoms. Neurobiol Dis 39(3):393-401, 2010
78. Nagel S et al: HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia 19(5):841-846, 2005
79. Ikeda T et al: The effect of opioids on thermoregulatory responses in humans and the special antishivering action of
meperidine.
Ann N Y Acad Sci 813:792-798, 1997
80. Al-Adwani A, Basu N:
Methadone and excessive sweating.
Addiction 99(2):259, 2004
81. Clemens KE, Klaschik E: Clinical experience with transdermal and orally administered opioids in palliative care patients—A retrospective study. Jpn J Clin Oncol 37(4):302-309, 2007
82. Hilz MJ et al: Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 127(Pt 9):2090-2098, 2004
83. Axelrod FB, Berlin D:
Pregabalin: A new approach to treatment of the dysautonomic crisis.
Pediatrics 124(2):743-746, 2009
84. Josephs KA et al: Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 21(6):440-445, 2004
85. Low PA et al: Chronic idiopathic anhidrosis. Ann Neurol 18(3):344-348, 1985
86. Murakami K et al: Acquired idiopathic generalized anhidrosis: a distinctive clinical syndrome. J Neurol 235(7):428-431, 1988
87. Chen YC et al: Identification of subgroups of acquired idiopathic generalized anhidrosis. Neurologist 14(5):318-320, 2008
88. Nakazato Y et al: Idiopathic pure sudomotor failure: Anhidrosis due to deficits in cholinergic transmission. Neurology 63(8):1476-1480, 2004
89. Faden AI, Chan P, Mendoza E: Progressive isolated segmental anhidrosis. Arch Neurol 39(3):172-175, 1982
90. Nolano M et al: Ross syndrome: A rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects. Brain 129(Pt 8):2119-2131, 2006
91. Nagane Y, Utsugisawa K: Ross syndrome associated with cytomegalovirus infection. Muscle Nerve 38(1):924-926, 2008
92. Shishido T et al: Alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology 74(7):608-610, 2010
93. Iodice V et al: Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology 72(23):2002-2008, 2009
94. Kimpinski K et al: Sudomotor dysfunction in autoimmune autonomic ganglionopathy. Neurology 73(18):1501-1506, 2009
95. Lipp A et al: Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 66(6):742-750, 2009
96. Sandroni P et al: Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res 1(2):147-155, 1991
97. Orimo S et al: Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Berl) 109(6):583-588, 2005
98. Thaisetthawatkul P et al: Autonomic dysfunction in dementia with Lewy bodies. Neurology 62(10):1804-1809, 2004
99. Hilz MJ: Assessment and evaluation of hereditary sensory and autonomic neuropathies with autonomic and neurophysiological examinations. Clin Auton Res 12(Suppl. 1):I33-I43, 2002
100. Wang AK et al: Patterns of neuropathy and autonomic failure in patients with amyloidosis. Mayo Clin Proc 83(11):1226-1230, 2008
101. van de Vosse E, Hoeve MA, Ottenhoff TH: Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4(12):739-749, 2004
102. Newsom-Davis J: Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris) 160(2):177-180, 2004
103. Low PA et al: The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain 98(3):357-364, 1975
104. Moller AT et al: Autonomic skin responses in females with Fabry disease. J Peripher Nerv Syst 14(3):159-164, 2009
105. Schiffmann R et al: Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease. J Pediatr 156(5):832-837, 837 e831, 2010
106. Lao LM et al: The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 18(2):109-117, 1998
107. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 15(2):79-92, 2010
108. Low
VA et al: Detection of small-fiber neuropathy by sudomotor testing.
Muscle Nerve 34(1):57-61, 2006
109. Davis MD et al: Erythromelalgia: Vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol 139(10):1337-1343, 2003
110. Davis MD et al: Histopathologic findings in primary erythromelalgia are nonspecific: Special studies show a decrease in small nerve fiber density. J Am Acad Dermatol 55(3):519-522, 2006
111. Davis MD et al: Thermoregulatory sweat testing in patients with erythromelalgia. Arch Dermatol 142:1-6, 2006
112. Drummond PD, Finch PM: Reflex control of facial flushing during body heating in man. Brain 112(Pt 5):1351-1358, 1989
113. Umeki S et al: Harlequin syndrome (unilateral flushing and sweating attack) due to a spinal invasion of the left apical lung cancer. Rinsho Shinkeigaku 30(1):94-99, 1990
114. Donaghy M: Neurologists and the threat of bioterrorism. J Neurol Sci 249(1):55-62, 2006
115. Ben-Zeev B et al: Oligohydrosis and hyperthermia: Pilot study of a novel
topiramate adverse effect.
J Child Neurol 18(4):254-257, 2003
116. de Carolis P et al: Transient hypohidrosis induced by
topiramate.
Epilepsia 44(7):974-976, 2003
117. Antonovich DD et al: Infectious eccrine hidradenitis caused by Nocardia. J Am Acad Dermatol 50(2):315-318, 2004
118. Niyonsaba F et al: The human antimicrobial peptide dermcidin activates normal human keratinocytes. Br J Dermatol 160(2):243-249, 2009
119. Naimer SA et al: Plantar hidradenitis in children induced by exposure to wet footwear. Pediatr Emerg Care 16(3):182-183, 2000
120. Bilic M, Mutasim DF: Neutrophilic eccrine hidradenitis in a patient with Behcet's disease. Cutis 68(2):107-111, 2001
121. Pipitone N et al: New approaches in the treatment of Adamantiades-Behcet's disease. Curr Opin Rheumatol 18(1):3-9, 2006
122. Sfikakis PP: Behcet's disease: A new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51-ii53, 2002
123. Mitchell J et al: Anhidrosis (hypohidrosis) in Sjogren's syndrome. J Am Acad Dermatol 16(1 Pt 2):233-235, 1987
124. Sais G et al: Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjogren's syndrome. Br J Dermatol 139(6):1073-1076, 1998
125. Cavill D, Waterman SA, Gordon TP: Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjogren's syndrome. Scand J Immunol 59(3):261-266, 2004
126. Dawson LJ et al: Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54(4):1165-1173, 2006
127. Li J et al: Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome. Lab Invest 84(11):1430-1438, 2004
128. Waterman SA, Gordon TP, Rischmueller M: Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum 43(7):1647-1654, 2000
129. Nakazato Y et al: A case of Sjogren's syndrome with heat intolerance induced by generalized anhidrosis as its principal feature. Rinsho Shinkeigaku 42(2):171-174, 2002
130. Horsefield R et al: High-resolution x-ray structure of human aquaporin 5. Proc Natl Acad Sci U S A 105(36):13327-13332, 2008
131. Ma L et al: Postnatal expression and denervation induced up-regulation of aquaporin-5 protein in rat sweat gland. Cell Tissue Res 329(1):25-33, 2007
132. Paquette DL, Falanga V: Cutaneous concerns of scleroderma patients. J Dermatol 30(6):438-443, 2003
133. Moss C, Ince P: Anhidrotic and achromians lesions in incontinentia pigmenti. Br J Dermatol 116(6):839-849, 1987
134. Koga M. Vitiligo: A new classification and therapy. Br J Dermatol 97(3):255-261, 1977
135. Koga M, Tango T: Clinical features and course of type A and type B vitiligo. Br J Dermatol 118(2):223-228, 1988
136. Beljan G, Metze D: [Miliaria and follicular atrophodermia as an early sign of Bazex-Dupre-Christol syndrome]. J Dtsch Dermatol Ges 2(7):602-604, 2004
137. Shuster S: Duct disruption, a new explanation of miliaria. Acta Derm Venereol 77(1):1-3, 1997
138. Haas N, Henz BM, Weigel H: Congenital miliaria crystallina. J Am Acad Dermatol 47(5 Suppl.):S270-S272, 2002
139. Haas N, Martens F, Henz BM: Miliaria crystallina in an intensive care setting. Clin Exp Dermatol 29(1):32-34, 2004
140. Holzle E, Kligman AM: The pathogenesis of miliaria rubra. Role of the resident microflora. Br J Dermatol 99(2):117-137, 1978
141. Mowad CM et al: The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 33(5 Pt 1):729-733, 1995
142. Badertscher K et al: Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 296(10):503-506, 2005
143. Jarvikallio A, Harvima IT, Naukkarinen A: Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295(1):2-7, 2003
144. Rippke F et al: Stratum corneum pH in atopic dermatitis: Impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol 5(4):217-223, 2004
145. Rieg S et al: Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174(12):8003-8010, 2005
146. Schittek B et al: The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8(3):135-143, 2008
147. Hata TR, Gallo RL: Antimicrobial peptides, skin infections, and atopic dermatitis. Semin Cutan Med Surg 27(2):144-150, 2008
148. Lee H et al: Gene delivery to human sweat glands: A model for cystic fibrosis gene therapy. Gene Ther 12(24):1752-1760, 2005
149. Berk DR et al: Aquagenic wrinkling of the palms in cystic fibrosis: Comparison with controls and genotype-phenotype correlations. Arch Dermatol 145(11):1296-1299, 2009
150. Katz KA, Yan
AC, Turner ML: Aquagenic wrinkling of the palms in patients with cystic fibrosis homozygous for the delta F508 CFTR mutation.
Arch Dermatol 141(5):621-624, 2005
151. Kabashima K et al: Aberrant aquaporin 5 expression in the sweat gland in aquagenic wrinkling of the palms. J Am Acad Dermatol 59(2 Suppl. 1):S28-S32, 2008